ReviewAIDS research and treatment2026
Prevalence of Hypertension, Diabetes, Obesity, and High Cholesterol Among Older People Living With HIV: A Systematic Review and Meta-Analysis.
Review in AIDS research and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Metabolic comorbidities are significant health challenges for older people living with HIV (PLHIV). This systematic review and meta-analysis aimed to synthesize existing evidence and provide the pooled prevalence of metabolic comorbidities among older PLHIV worldwide. Methods: We searched PubMed, Web of Science, Embase, Scopus, and Google Scholar for English-language documents from 2013 to 25 December 2023. To identify unpublished documents for a grey literature review, we reached out to well-known experts in HIV and aging, asking them to provide and share unpublished records, and we searched the first 300 articles in Google Scholar. We included cross-sectional studies and baseline data from cohort studies to measure the prevalence of metabolic comorbidities, including hypertension, obesity, diabetes, and high cholesterol. The pooled prevalence and 95% confidence interval (CI) of metabolic comorbidities were estimated using random effects meta-analysis. Results: Of the 915 articles recruited articles for full text, 26 studies (including 10 in developed countries) met the inclusion criteria and were included in the analysis. Most of the studies were conducted in North America. The pooled prevalence of individual metabolic comorbidities was as follows: diabetes (20 articles) 13.5% (95% CI: 10.0, 17.4), high cholesterol (eight articles) 47.3% (95% CI: 36.3, 58.4), hypertension (22 articles) 40.7% (95% CI:30.2, 51.2), and obesity (10 articles) 26.1% (95% CI:20.3, 32.4). The results showed that the prevalence of all metabolic comorbidities was higher in North America. Conclusion: We found that metabolic comorbidities are a common condition among older PLHIV and represent a significant risk factor for various diseases. Policymakers should consider implementing practical interventions, including prevention strategies, periodic screenings, and lifestyle modifications focused on promoting a healthy diet and regular exercise to manage metabolic comorbidities in older PLHIV effectively. Most studies have been conducted in developed countries; there is a need for increased research efforts in other regions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.